MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks
Home » Kent Imaging inks wound care imaging deal with SerenaGroup

Kent Imaging inks wound care imaging deal with SerenaGroup

June 27, 2018 By Fink Densford Leave a Comment

Share

Kent Imaging, SerenaGroup

Kent Imaging said today it inked a strategic partnership with SerenaGroup aiming to improve wound tissue assessments.

Through the deal, wound healing research firm SerenaGroup will adopt use of Kent’s KD203 near infrared imaging technology designed for measuring oxygenation, which Calgary, U.K.-based Kent Imaging touted as the “best biomarker” of tissue healing.

“We are pleased to introduce Kent’s imaging system into the wound care protocol at our clinics. One of the most troublesome and elusive criteria in treating wounds is the timely and accurate assessment of viable tissue. Kent’s device will propel us a long way down the healing path with a technology that has been lacking across the board in the Wound Care space,” SerenaGroup founder & medical director Dr. Serena said in a prepared statement.

The KD203 device reports oxygen saturation, relative oxyhemoglobin levels and relative deoxyhemoglobin levels in superficial tissue. The system displays a 2D color-coded image to aid clinicians in determining at risk tissue and improve treatment decisions, Kent said.

“Our joint belief is that we can improve patient care and outcomes by significantly improving clinically relevant data that is required to assess and manage wounds. We are excited to be partnering with SerenaGroup and with Dr. Serena who has dedicated his career to improving patient outcomes in wound care,” Kent Imaging CEO Pierre Lemire said in a press release.

Filed Under: Business/Financial News, Imaging, Wound Care Tagged With: kentimaging

In case you missed it

  • Judge sends ‘brain fingerprinting company’ and would-be distributor to arbitration
  • FDA gives massive Medtronic recall Class I designation
  • Affluent Medical touts results of endovascular aneurysm repair study
  • NeoTract’s UroLift system gains expanded insurance coverage
  • Innovasive rebrands as Amplify Surgical
  • Report: FDA panel wants more extensive data, quality of life outcomes for vaginal mesh products
  • These medtech companies raised the most VC in 2018
  • IEEE publishes safety standards draft for medtech interoperability
  • Senseonics partners to provide veterans with Eversense CGM
  • FDA goes after California stem cell doc for unapproved breast implant device
  • FTC wants more details on $4B Boston Scientific-BTG tie-up
  • Tandem wins interoperable claim for insulin pump from FDA
  • Nevro files patent infringement suit against Stimwave
  • A record year for device innovation
  • Soterix Medical launches tDCS trial for cocaine addiction
  • Corindus asks FDA for expanded neurosurgery indication for CorPath GRX
  • FDA green-lights early feasibility trial for Foldax’s Tria biopolymer heart valve

RSS From Medical Design & Outsourcing

  • Empowering Medical Innovation
    From faster medical device development to life-saving surgical planning models, see how full-color, multi-material 3D printing opens up broad possibilities for medical innovation. In this new E-book you’ll learn how the Stratasys J750 can: Produce superior medical models for surgical planning and training Foster better medical devices through faster ideation and prototyping Enable advanced training… […]
  • Affluent Medical touts results of endovascular aneurysm repair study
    Medtech startup Affluent Medical(Paris, France) said a study of its endovascular aneurysm repair (EVAR) system device showed patients had fewer endoleaks and needed fewer secondary interventions, and that their aneurysms shrank in volume and diameter. The company’s Kardiozis endovascular prosthesis uses thrombogenic fibers to embolize an abdominal aortic aneurism sac during a conventional EVAR procedure to prevent… […]
  • This cotton-based biofuel cell could power implanted medical devices
    Researchers at the Georgia Institute of Technology and Korea University have developed a glucose-powered biofuel cell that uses electrodes from cotton that could potentially power implantable medical devices. The fuel cell has twice as much power as traditional biofuel cells and could also be paired with batteries or super capacitors to create a hybrid power… […]
  • IEEE publishes safety standards draft for medtech interoperability
    The Institute of Electrical and Electronics Engineers (IEEE) Standards Association said it has published a draft set of standards intended to provide safe and secure medical device interoperability. IEEE 11073-20701-2018, also known as IEEE Approved Draft Standard for Service-Oriented Medical Device Exchange Architecture & Protocol Binding, completes the International Organization for Standardization (ISO)/IEEE 11073 family of standards… […]
  • FDA clears Safe Medical Design’s urethral catheter
    Safe Medical Design (San Francisco) said that FDA has cleared its Signal Catheter for commercialization in the United States. The 100% silicone foley catheter features a novel hub design allowing the catheter to reduce excessive balloon pressure in the event the catheter is improperly placed. Each year in the United States there are as many as 500,000… […]
  • These medtech companies raised the most VC in 2018
    Venture capital firms invested more than $2.9 billion in medical device companies in 2018 — a slight increase from the $2.8 billion raised in 2017, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Both the first and second quarters of 2018 saw an increase in investments, totaling nearly $778 million and $786 million respectively.… […]
  • ODU touts Medi-Snap Advanced plastic circular connector for medical applications
    ODU (Camarillo, Calif.) recently announced that it is introducing its Medi-Snap Advanced plastic circular connector to the North American market. ODU describes the Medi-Snap as lightweight and cost-efficient. It’s a plastic circular connector with high chemical resistance ideal for medical, industrial and test and measurement applications, according to the company. The autoclavable connector is IEC 60601-1 compliant and… […]
  • Regulatory software company Complion raises $7M
    Complion (Cleveland) — a maker of regulatory software for clinical research sites — recently announced that it has raised $7 million in its latest funding round. Beringea led the Series B round, the company announced on Feb. 12. The round ended up being oversubscribed, thanks to interest from existing investors including the Ohio Innovation Fund, JumpStart… […]
  • These new titanium strip grades could enable better neuromodulation devices
    Officials at Ametek Specialty Metal Products (Collegeville, Pa.) think their new titanium strip grades for medical applications could enable more innovation in the fast-growing neuromodulation device sector. Ametek’s Hamilton Precision Metals and SMP Wallingford businesses have proprietary production processes for the new titanium grades — grades 9 and 23. They manufacture thin strips of the titanium through cold… […]
  • CoorsTek Bioceramics touts composite ceramic material
    CoorsTek Bioceramics officials think testing and clinical feedback since 2011 has shown their CeraSurf-p alumina matrix composite ceramic material to be a state-of-the-art ceramic bearing material for total hip arthroplasty. CoorsTek’s CeraSurf-p is an implant grade alumina matrix composite ceramic material that falls under the ISO 6474-2 Type X (extra high strength) material standard. The proprietary material… […]
  • Life Spine launches sacroiliac screw study
    Life Spine (Huntley, Ill.) said it has begun a study of sacroiliac joint fixation outcomes using its SImpact screw. SImpact is a cannulated and fenestrated screw, intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis through a lateral approach. It incorporates the proprietary surface technology Osseo-Loc, and is available in… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS